Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review

European Urology

Volumn 73, Issue 1, 2018, Pages 40-50

  Fonteyne, Valérie ^a   Ost, Piet ^a   Bellmunt, Joaquim ^b   Droz, Jean Pierre ^c   Mongiat Artus, Pierre ^d   Inman, Brant ^e   Paillaud, Elena ^f   Saad, Fred ^g   Ploussard, Guillaume ^h  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITÉ LYON 1   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f HENRI MONDOR HOSPITAL   (France)

^g Institut du Cancer de Montreal   (Canada)

^h Saint Jean Languedoc Clinic   (France)

Author keywords

Complications; Elderly; MIBC; Outcome

Indexed keywords

AGED; CANCER MORTALITY; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL EVALUATION; CLINICAL OUTCOME; COMPARATIVE STUDY; GERIATRIC ASSESSMENT; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; SYSTEMATIC REVIEW; AGE; BLADDER TUMOR; CLINICAL DECISION MAKING; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOLOGY; PATIENT SELECTION; QUALITY OF LIFE; RADIOTHERAPY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CLINICAL DECISION-MAKING; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; PATIENT SELECTION; QUALITY OF LIFE; RADIOTHERAPY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 85018973788     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2017.03.019     Document Type: Review

References (71)

1. Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., Bray, F., Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71 (2016), 96–108.
2. Witjes, J.A., Lebret, T., Compérat, E.M., et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71 (2017), 462–475.
3. Extermann, M., Aapro, M., Bernabei, R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55 (2005), 241–252.
4. Moga C, Schopflocher D, Hartstall C. Development of a quality appraisal tool for case series studies using a modified Delphi technqiue. Institute of Health Economics. http://www.ihe.ca.
5. Hafron, J., Mitra, N., Dalbagni, G., Bochner, B., Herr, H., Donat, S.M., Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. J Urol 173 (2005), 1513–1517.
6. Horovitz, D., Turker, P., Bostrom, P.J., et al. Does patient age affect survival after radical cystectomy?. BJU Int 110 (2012), 486–493.
7. Figueroa, A.J., Stein, J.P., Dickinson, M., et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 83 (1998), 141–147.
8. Rink, M., Dahlem, R., Kluth, L., et al. Older patients suffer from adverse histopathological features after radical cystectomy. Int J Urol 18 (2011), 576–584.
9. Liberman, D., Lughezzani, G., Sun, M., et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 77 (2011), 660–666.
10. Pollack, A., Zagars, G.K., Dinney, C.P., Swanson, D.A., Von Eschenbach, A.C., Preoperative radiotherapy for muscle-invasive bladder carcinoma: Long term follow-up and prognostic factors for 338 patients. Cancer 74 (1994), 2819–2827.
11. Guillotreau, J., Miocinovic, R., Gam, X., et al. Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients. Urology 79 (2012), 585–590.
12. Fontana, P.P., Gregorio, S.A., Rivas, J.G., et al. Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years. Cent European J Urol 68 (2015), 24–29.
13. Bostrom, P.J., Mirtti, T., Kossi, J., Laato, M., Nurmi, M., Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre. Scand J Urol Nephrol 43 (2009), 357–364.
14. Nishiyama, H., Habuchi, T., Watanabe, J., et al. Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 45 (2004), 176–181.
15. Leveridge, M.J., Siemens, D.R., Mackillop, W.J., et al. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study. Urology 85 (2015), 791–798.
16. Fairey, A.S., Kassouf, W., Aprikian, A.G., et al. Age >80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database. Urol Oncol 30 (2012), 825–832.
17. Patel, M.I., Bang, A., Gillatt, D., Smith, D.P., Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study. BJU Int 116 (2015), 18–25.
18. Hara, T., Matsuyama, H., Kamiryo, Y., et al. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer. Int J Clin Oncol 21 (2016), 139–147.
19. Dalbagni, G., Genega, E., Hashibe, M., et al. Cystectomy for bladder cancer: a contemporary series. J Urol 165 (2001), 1111–1116.
20. Zakaria, A., Santos, F., Kassoul, W., Tanguay, S., Aprikian, A., Survival after radical cystectomy for bladder cancer in relation to prior non-muscle invasive disease in Quebec. Urol Int 97 (2016), 49–53.
21. Chromecki, T.F., Mauermann, J., Cha, E.K., et al. Multicenter validation of the prognostic value of patient age in patients treated with curative cystectomy. World J Urol 30 (2012), 753–759.
22. Gore, J.L., Kwan, L., Saigal, C.S., Litwin, M.S., Marriage and mortality in bladder carcinoma. Cancer 104 (2005), 1188–1194.
23. Morgan, T.M., Barocas, D.A., Penson, D.F., et al. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. J Urol 80 (2012), 632–640.
24. Goossens-Laan, C.A., Leliveld, A.M., Verhoeven, R.H., et al. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer. Int J Cancer 135 (2014), 905–912.
25. Hayter, C.R., Paszat, L.F., Groome, P.A., Schulze, K., Mackillop, W.J., A population-based study of the use and outcome of radical radiotherapy for invaisve bladder cancer. Int J Radiat Oncol Biol Phys 45 (1999), 1239–1245.
26. Thrasher, J.B., Frazier, H.A., Robertson, J.E., Dodge, R.K., Paulson, D.F., Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 73 (1994), 1708–1715.
27. Yamanaka, K., Miyake, H., Hara, I., Inoue, T.A., Fujisawa, M., Significance of radical cystectomy for bladder cancer in patients over 80 years old. Int Urol Nephrol 39 (2007), 209–214.
28. Nielsen, M.E., Shariat, S.F., Karakiewicz, P.I., et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51 (2007), 699–708.
29. Madersbacher, S., Bauer, W., Willinger, M., Wehrberger, C., Berger, I., Brössner, C., Radical cystectomy for bladder cancer in the 70+ population: a nation-wide registry analysis of 845 patients. Urol Int 85 (2010), 287–290.
30. Donat, S.M., Siegrist, T., Cronin, A., Savage, C., Milowsky, M.I., Herr, H.W., Radical cystectomy in octogenarians–does morbidity outweigh the potential survival benefits?. J Urol 183 (2010), 2171–2177.
31. Dotan, K., Kavanagh, O., Yossepowitch, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 178 (2007), 2308–2313.
32. Mak, R.H., Hunt, D., Shipley, W.U., et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 32 (2014), 3801–3809.
33. Fossa, S.D., Waehre, H., Aass, N., Jacobsen, A.B., Olsen, D.R., Ous, S., Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72 (1993), 3036–3043.
34. Knap, M.M., Lundbeck, F., Overgaard, J., Early and late treatment-related morbidity following radical cystectomy. Scan J Urol Nephrol 38 (2004), 153–160.
35. Clark, P.E., Stein, J.P., Groshen, S.G., et al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 104 (2005), 36–43.
36. Roghmann, F., Sukumar, S., Ravi, P., et al. Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care. Urol Int 92 (2014), 27–34.
37. Tilki, D., Reich, O., Karakiewicz, P.I., et al. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol 58 (2010), 112–117.
38. Schiffmann, J., Larcher, A., Sun, M., et al. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol 40 (2014), 1738–1745.
39. Novotny, V., Fröhner, M., Zastrow, S., Oehlschlaeger, S., Weißflog, C., Wirth, M.P., C94 Radical cystectomy in patients over 75 years of age with one or more severe comorbidities. Eur Urol Suppl, 11, 2012, 104.
40. Fairey, A., Chetner, M., Metcalfe, J., et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta urology Institute Radical cystectomy database. J Urol 180 (2008), 128–134.
41. Morgan, T.M., Keegan, K.A., Barocas, D.A., et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol 186 (2011), 829–834.
42. Abdollah, F., Sun, M., Schmitges, J., et al. Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study. Ann Surg Oncol 19 (2012), 309–317.
43. Isbarn, H., Karakiewicz, P.I., Shariat, S.F., et al. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. J Urol 182 (2009), 459–465.
44. Schmid, M., Rink, M., Traumann, M., et al. Evidence from the ‘PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)’ study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?. Ann Surg Oncol 22 (2015), 1032–1042.
45. Fedeli, U., Galassi, C., Ficarra, V., et al. Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy. Br J Urol 108 (2010), 266–271.
46. Efstathiou, J.A., Bae, K., Shipley, W.U., et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol 27 (2009), 4055–4061.
47. Gray, P.J., Fedewa, S.A., Shipley, W.U., et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Euro Urol 63 (2013), 823–829.
48. Konety, B.R., Joslyn, S.A., Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170 (2003), 1765–1771.
49. Noon, A.P., Albertsen, P.C., Thomas, F., Rosario, D.J., Catto, J.W., Competing mortlaity in patients diagnosed with bladder cancer: evidence of udnertreatment in the elderly and female patients. Br J Cancer 108 (2013), 1534–1540.
50. Cao, J., Zhao, X., Zhong, Z., Zhang, L., Zhu, X., Xu, R., Prognostic value of pre-operative renal insufficiency in urothelial carcinoma: a systematic review and meta-analysis. Sci Rep, 6, 2016, 35214.
51. Walter, L.C., Schonberg, M.A., Screening mammography in older women: a review. JAMA 311 (2014), 1336–1347.
52. Marshall, V.F., Whitmore, W.F., The surgical treatment of cancers of the urinary bladder. Cancer 9 (1956), 609–619.
53. Bream, M., Maurice, M., Altschuler, J., Zhu, H., Abouassaly, R., Increased use of cystectomy in patients 75 or older: a contemporary analysis of survival and perioperative outcomes from the National Cancer database. Urology 100 (2017), 72–78.
54. Caillet, P., Canoui-Poitrine, F., Vouriot, J., et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 29 (2011), 3636–3642.
55. Decoster, L., Van Puyvelde, K., Mohile, S., et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26 (2015), 288–300.
56. Hollenbeck, B.K., Miller, D.C., Taub, D., et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 64 (2004), 292–297.
57. Advanced Bladder Cancer Overview Collaboration. Neoadjuvant chemotherapy for invasive bladder cancer. Cochrane database Syst Rev, 2005, CD005246.
58. Abdollah, F., Sun, M., Shariat, S.F., et al. The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 national comprehensive cancer network practice guidelines for bladder cancer treatment. J. Urol 185 (2011), 2078–2084.
59. Reardon, Z.D., Patel, S.G., Zaid, H.B., et al. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Eur Urol 67 (2015), 165–170.
60. Launay-Vacher, V., Oudard, S., Janus, N., et al. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 110 (2007), 1376–1384.
61. Chau, C.S.Y., Wheater, M.J., Geldart, T.R., Crabb, S.J., Comparison of cisplatin-based neoadjuvant chemotherapy for bladder cancer in elderly versus younger patients. J Clin Oncol, 32, 2014, 15.
62. Larcher, A., Sun, M., Schiffmann, J., et al. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. Eur J Surg Oncol 41 (2015), 353–360.
63. Koppie, T.M., Vickers, A.J., Vora, K., Dalbagni, G., Bochner, B.H., Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?. Cancer 107 (2006), 2368–2374.
64. May, M., Herrmann, E., Bolenz, C., et al. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 18 (2011), 2018–2025.
65. Sogni, F., Brausi, M., Frea, B., et al. Morbidity and quality of life in elderly patients receiving ileal conduit of orthotopic neobladder after radical cystectomy for invaisve bladder cancer. Urology 71 (2008), 919–923.
66. Prout, G.R., Wesley, M.N., Yancik, R., Ries, L.A., Havlik, R.J., Edwards, B.K., Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104 (2005), 1638–1647.
67. Froehner, M., Brausi, M.A., Herr, H.W., Muto, G., Studer, U.E., Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56 (2009), 443–454.
68. Schaffar, R., Rapiti, E., Rachet, B., Woods, L., Accuracy of cause of death data routinely recorded in a population-based cancer registry: impact on cuase-specific survival and validation using the Geneva Cancer Registry. BMC Cancer, 13, 2013, 609.
69. Mieno, M.N., Tanaka, N., Ara, T., et al. Accuracy of death certificates ans assessment of factors for misclassification of underlying cause of death. J Epidemiol 26 (2016), 191–198.
70. Bellmunt, J., Orsola, A., Maldonado, X., Kataja, V., Group, E.G.W., Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:Suppl 5 (2010), 134–136.
71. Kouloulias, V., Mosa, E., Tolia, M., et al. Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer. J BUON 18 (2013), 942–948.